2009
DOI: 10.1590/s1516-44462009000200010
|View full text |Cite
|
Sign up to set email alerts
|

Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder

Abstract: OBJECTIVE: In the present study, we investigate the association between the val66met polymorphism of the brain-derived neurotrophic factor (BNDF) and the performance on the Wisconsin Card Sorting Test in a sample of Caucasian Brazilian patients with bipolar disorder. METHOD: Sixty-four patients with bipolar disorder were assessed and their performance on the Wisconsin Card Sorting Test was compared with the allele frequency and genotype of the val66met polymorphism of the brain-derived neurotrophic factor. RES… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
18
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(22 citation statements)
references
References 23 publications
2
18
2
Order By: Relevance
“…3 The authors found that the percentage of non-perseverative errors was significantly higher in Val/Val carriers, thus contradicting previous findings on cognitive impairment in Met allele carriers. 1,2 Considering the relationship between BDNF and processes of memory and learning, as well as the existence of episodic deficits in bipolar patients even when euthymic, 4,5 we launched an investigation into the relationship between the Val66Met polymorphism and the performance in verbal and visual episodic memory tasks (COEP UFMG process approval number 018/09).…”
mentioning
confidence: 60%
See 1 more Smart Citation
“…3 The authors found that the percentage of non-perseverative errors was significantly higher in Val/Val carriers, thus contradicting previous findings on cognitive impairment in Met allele carriers. 1,2 Considering the relationship between BDNF and processes of memory and learning, as well as the existence of episodic deficits in bipolar patients even when euthymic, 4,5 we launched an investigation into the relationship between the Val66Met polymorphism and the performance in verbal and visual episodic memory tasks (COEP UFMG process approval number 018/09).…”
mentioning
confidence: 60%
“…Thus, our initial results are partly different from those found by Tramontina et al These differences could be attributed to sample characteristics since bipolar disorder is a heterogeneous clinical condition and certain patient subgroups may exhibit more severe cognitive impairments than others. 3 Certain limitations of this study must be noted. The sample is small and all subjects were using pharmacological therapy during the study.…”
mentioning
confidence: 88%
“…One of the biological markers is the brain-derived neurotrophic factor (BDNF), a marker for central nervous system neuroplasticity. 39 This marker is associated with the effect of therapeutic molecules and it is utilized as a guide for indentifying new treatments. Considering the importance of growth factors in inflammation and oncology, the effects of BDNF are also being evaluated for use in such medical fields.…”
Section: Discussionmentioning
confidence: 99%
“…Study examining 64 people with bipolar disorder, displayed significantly more non-perseverative errors in the group homozygous for Val allele [20]. Cunha et al showed that moderate BDNF overexpression in rats may lead to impaired learning in spatial and instrumental memory tasks.…”
Section: Brain-derived Neurotrophic Factor Val66met Polymorphism In Cmentioning
confidence: 99%
“…In some studies Met allele is considered to deteriorate cognitive functioning, while other studies do not present any significant associations between BDNF Val66Met and cognition [9,[20][21][22].…”
Section: Introductionmentioning
confidence: 99%